Related Experiment Video
Updated: Feb 4, 2026

A Virtual Machine Platform for Non-Computer Professionals for Using Deep Learning to Classify Biological Sequences of Metagenomic Data
Published on: September 25, 2021
Sparse Treatment-Effect Model for Taxon Identification with High-Dimensional Metagenomic Data
1Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. ailliuzx@cshs.org.
A new method, STEMIT, identifies disease-associated microbes by considering interactions and providing P-values for statistical inference in metagenomics. This approach enhances understanding of complex microbial communities and their links to disease.
Area of Science:
- Metagenomics
- Microbiome analysis
- Statistical inference
Background:
- Identifying disease-associated taxa is crucial in metagenomics.
- Existing methods often neglect taxon interactions or lack P-value generation.
- There's a need for methods that combine interaction analysis with statistical significance.
Purpose of the Study:
- To introduce a novel statistical model, STEMIT (STatistical Effective Model for Identifying Taxa), for high-dimensional metagenomic data.
- To enable identification of disease-associated taxa while considering their interactions.
- To provide P-values for statistical inference and potential causal inference in clinical trials.
Main Methods:
- STEMIT utilizes a two-step treatment-effect maximization approach.
- Sparse modeling identifies taxa associated with treatment-effect and target features.
- Ordinary Least Squares (OLS) regression estimates the P-value for the target taxon.
Main Results:
- The proposed STEMIT method demonstrates efficiency in identifying important taxa.
- The method was successfully applied to a real-world metagenomic dataset.
- STEMIT provides P-values, enabling robust statistical inference.
Conclusions:
- STEMIT offers a significant advancement in analyzing high-dimensional metagenomic data.
- The model effectively identifies disease-associated taxa by accounting for interactions.
- STEMIT facilitates deeper insights into microbiome-disease relationships and supports causal inference.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Dimensional Analysis
Conversion Factors and Dimensional Analysis
The unit...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
One-Compartment Open Model: Urinary Excretion Data and Determination of k

